Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Demographic and clinical data were collected, and symptoms were assessed using the Zung Self-Rating Depression Scale (SDS), Zung Self-Rating Anxiety Scale (SAS), 9-item Fatigue Severity Scale (FSS), Pittsburgh Sleep Quality Index (PSQI), and Stroke Stigma Scale (SSS) at baseline (T1), one month (T2), three months (T3), and six months (T4) post-stroke
ATTAIN 1 clinical trial demonstrates that individuals with overweight and obesity who used the highest dose of orforglipron (36 mg) lost 12.4% of body weight after 72 weeks
Another frequent mistake involves unit versus milliliter confusion
This systematic approach ensures at least 4 weeks between injections in the same spot, giving tissue time to recover
Storage Instructions Proper storage is important to ensure the medication remains effective
CGM technology with and without insulin pump therapy is an emerging attractive approach to help insulin-treated people with DKD optimise their glycaemic control
